About

Dr. Houda Bahig is a radiation oncologist whose research centers on precision radiotherapy for thoracic and head-and-neck cancers, with a particular focus on stereotactic body radiotherapy (SBRT) for lung cancer. Her major contributions include demonstrating excellent cancer outcomes with patient-adapted robotic lung SBRT, while also identifying critical risks—such as caution in idiopathic pulmonary fibrosis patients (33 citations). She has advanced understanding of long-term quality of life in early-stage non-small cell lung cancer patients treated with robotic stereotactic ablative radiation therapy (24 citations) and compared local control and distant metastasis between CyberKnife and conventional SBRT (21 citations). Dr. Bahig has also investigated breath-hold CT accuracy for lung SBRT treatment planning and explored toxicity and pharyngeal dysphagia outcomes from intensity-modulated proton therapy for oropharyngeal squamous cell cancer. Her work bridges technical innovation and patient-centered outcomes, informing safer, more effective radiotherapy protocols. With over 80 citations across her key publications, Dr. Bahig’s research continues to shape clinical practice in lung and head-and-neck radiation oncology, emphasizing personalized treatment adaptation and quality-of-life preservation.

Research Focus

Key Achievements

3
H-Index
5
Papers
82
Total Citations
16
Avg Citations/Paper
🏆 Most Cited Paper
Excellent Cancer Outcomes Following Patient-adapted Robotic Lung SBRT But a Case for Caution in Idiopathic Pulmonary Fibrosis
33 citations · 2014
📈 Most Prolific Year: 2014 (2 Papers)
🤝 Key Collaborators: 41
🏛 Institutions: Centre Hospitalier de l’Université de Montréal, The University of Texas MD Anderson Cancer Center

Top Papers

  1. 1
  2. 2
  3. 3
  4. 4
  5. 5

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 13 days ago